I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) surged more than 8% during regular trading to $12.20.
The stock is down 24.57% over the past ten sessions and sits 26.29% above its 52-week low of US$9.660. The intraday swing reached 10.04%.
The Nasdaq Composite is down 4.15% over the past five sessions and up 9.19% year to date.
Based on public media reports. AI-generated; not investment advice.